SHOULD PATIENTS WITH UNRESECTABLE CHOLANGIOCARCINOMA AND JAUNDICE BE MANAGED VIA ENDOSCOPY WITH STENTS, INTERVENTIONAL RADIOLOGISTS WITH DRAINS, OR BOTH?

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Cholangiocarcinoma is the second most common primary liver tumor, but overall it is rare. Its incidence, like that of hepatocellular carcinoma, is on the rise. Patients may be diagnosed with cholangiocarcinoma early if the common hepatic or common bile duct is involved. In these patients, biliary obstruction and jaundice will develop, and the patient will seek treatment earlier in the course of the disease. If the tumor is perihilar or intrahepatic, jaundice may not develop for some time, and the disease is more likely to be advanced at the time of diagnosis.

Original languageEnglish (US)
Title of host publicationCurbside Consultation in GI Cancer for the Gastroenterologist
Subtitle of host publication49 Clinical Questions
PublisherCRC Press
Pages145-150
Number of pages6
ISBN (Electronic)9781040140659
ISBN (Print)9781556429842
DOIs
StatePublished - Jan 1 2024

All Science Journal Classification (ASJC) codes

  • General Medicine

Fingerprint

Dive into the research topics of 'SHOULD PATIENTS WITH UNRESECTABLE CHOLANGIOCARCINOMA AND JAUNDICE BE MANAGED VIA ENDOSCOPY WITH STENTS, INTERVENTIONAL RADIOLOGISTS WITH DRAINS, OR BOTH?'. Together they form a unique fingerprint.

Cite this